Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.

Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ.

J Diabetes Complications. 2016 Mar;30(2):212-20. doi: 10.1016/j.jdiacomp.2015.11.016. Epub 2015 Nov 17.

2.

Verification and Validation of Health Economic Models for Diabetes.

Boye KS, Lage ME, Lage MJ, Valentine WJ, Pollock RF, Saunders R.

Value Health. 2015 Nov;18(7):A702. doi: 10.1016/j.jval.2015.09.2626. Epub 2015 Oct 20. No abstract available.

PMID:
26533935
3.

Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States.

Eby EL, Van Brunt K, Brusko C, Curtis B, Lage MJ.

Clin Ther. 2015 Oct 1;37(10):2297-2308.e1. doi: 10.1016/j.clinthera.2015.08.004. Epub 2015 Sep 2.

4.

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.

Eby EL, Van Brunt K, Brusko C, Curtis B, Lage MJ.

Clin Interv Aging. 2015 Jun 17;10:991-1001. doi: 10.2147/CIA.S76398. eCollection 2015.

5.

Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.

Velligan DI, Carroll C, Lage MJ, Fairman K.

Psychiatr Serv. 2015 Feb 1;66(2):127-33. doi: 10.1176/appi.ps.201300085. Epub 2014 Oct 15.

PMID:
25321616
6.

The cost of absenteeism and short-term disability associated with colorectal cancer: a case-control study.

Yaldo A, Seal BS, Lage MJ.

J Occup Environ Med. 2014 Aug;56(8):848-51. doi: 10.1097/JOM.0000000000000186.

PMID:
25099411
7.
8.

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus.

Ascher-Svanum H, Lage MJ, Perez-Nieves M, Reaney MD, Lorraine J, Rodriguez A, Treglia M.

Diabetes Ther. 2014 Jun;5(1):225-42. doi: 10.1007/s13300-014-0065-z. Epub 2014 Apr 30.

9.

Comparison of rates of and charges from pregnancy complications in users of extended and cyclic combined oral contraceptive (COC) regimens: a brief report.

Howard B, Trussell J, Grubb E, Lage MJ.

Contraception. 2014 May;89(5):396-9. doi: 10.1016/j.contraception.2013.12.006. Epub 2013 Dec 26.

10.

Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study.

Curtis B, Lage MJ.

J Med Econ. 2014 Jan;17(1):21-31. doi: 10.3111/13696998.2013.862538. Epub 2013 Nov 21.

PMID:
24195723
11.

Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report.

Howard B, Trussell J, Grubb E, Lage MJ.

Contraception. 2014 Jan;89(1):25-7. doi: 10.1016/j.contraception.2013.09.007. Epub 2013 Sep 21.

PMID:
24161474
12.

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus.

Mitchell BD, Eby EL, Lage MJ.

Curr Med Res Opin. 2013 Dec;29(12):1587-97. doi: 10.1185/03007995.2013.827108. Epub 2013 Sep 16.

PMID:
23886028
13.

Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment.

Lage MJ, Carroll CA, Fairman KA.

J Med Econ. 2013 Sep;16(9):1146-53. doi: 10.3111/13696998.2013.823868. Epub 2013 Aug 8.

PMID:
23844620
14.

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.

Eby EL, Boye KS, Lage MJ.

J Med Econ. 2013 Oct;16(10):1231-7. doi: 10.3111/13696998.2013.823091. Epub 2013 Jul 23.

PMID:
23834480
15.

Congenital echovirus 21 infection causing fulminant hepatitis in a neonate.

Pedrosa C, Lage MJ, Virella D.

BMJ Case Rep. 2013 Apr 9;2013. pii: bcr2012008394. doi: 10.1136/bcr-2012-008394.

16.

Burden of a multiple sclerosis relapse: the patient's perspective.

Oleen-Burkey M, Castelli-Haley J, Lage MJ, Johnson KP.

Patient. 2012;5(1):57-69. doi: 10.2165/11592160-000000000-00000.

PMID:
22217263
17.

The impact of comorbid depression on adherence to therapy for multiple sclerosis.

Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ.

Mult Scler Int. 2011;2011:271321. doi: 10.1155/2011/271321. Epub 2011 Aug 2.

18.

The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.

Oleen-Burkey MA, Dor A, Castelli-Haley J, Lage MJ.

J Med Econ. 2011;14(6):739-47. doi: 10.3111/13696998.2011.618517. Epub 2011 Sep 13.

PMID:
21913796
19.

Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer.

Lage MJ, Borker R, Barber B, Gao S.

J Med Econ. 2010;13(4):691-7. doi: 10.3111/13696998.2010.531829. Epub 2010 Nov 11.

PMID:
21070099
20.

Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts.

Castelli-Haley J, Oleen-Burkey MA, Lage MJ, Johnson K.

J Med Econ. 2010;13(3):464-71. doi: 10.3111/13696998.2010.496650.

PMID:
20662760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk